Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.

Goldman CK, Goldman JM

Open source

DOI
10.1111/jch.70353
Published
2026 Aug
Container
Journal of clinical hypertension (Greenwich, Conn.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/jch.70353,
  title = {Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.},
  author = {Goldman CK and Goldman JM},
  year = {2026},
  journal = {Journal of clinical hypertension (Greenwich, Conn.)},
  doi = {10.1111/jch.70353},
  url = {https://doi.org/10.1111/jch.70353}
}

RIS

TY  - JOUR
TI  - Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.
AU  - Goldman CK
AU  - Goldman JM
PY  - 2026
JO  - Journal of clinical hypertension (Greenwich, Conn.)
DO  - 10.1111/jch.70353
UR  - https://doi.org/10.1111/jch.70353
ER  - 

APA

CK, G., & JM, G. (2026). Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.. Journal of clinical hypertension (Greenwich, Conn.). https://doi.org/10.1111/jch.70353

Source records